Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
week omalizumab or placebo administered
săptămâna omalizumab sau placebo administrate
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
one vial contains 150 mg omalizumab.
un flacon conţine omalizumab 150 mg.
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
omalizumab studies 1 and 3 pooled
omalizumab studiile 1 şi 3 centralizate
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
one vial contains 150 mg of omalizumab.
un flacon conţine omalizumab 150 mg.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
xolair 150 mg solution for injection omalizumab
xolair 150 mg soluţie injectabilă omalizumab
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
the active substance of xolair is omalizumab.
substanţa activă din xolair este omalizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
there are no human fertility data for omalizumab.
nu există date privind fertilitatea la om pentru omalizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
xolair 150 mg solution for injection omalizumab sc use
xolair 150 mg soluţie injectabilă omalizumab administrare s. c.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
1 ml solution for injection contains 150 mg omalizumab.
1 ml soluţie injectabilă conţine 150 mg omalizumab.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
xolair 150 mg powder for solution for injection omalizumab
xolair 150 mg pulbere pentru soluţie injectabilă omalizumab
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
xolair is also available in vials with 150 mg omalizumab.
xolair este disponibil şi sub formă de flacoane cu 150 mg omalizumab.
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
it is unknown whether omalizumab is excreted in human milk.
nu se cunoaşte dacă omalizumab se excretă în laptele uman.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in vitro, omalizumab forms complexes of limited size with ige.
in vitro, omalizumab formează cu ige complexe de dimensiuni limitate.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the maximum recommended dose is 600 mg omalizumab every two weeks.
doza maximă recomandată este de 600 mg omalizumab la fiecare două săptămâni.
Last Update: 2017-04-26
Usage Frequency: 7
Quality:
the active substance in xolair, omalizumab, is a monoclonal antibody.
substanţa activă din xolair, omalizumabul, este un anticorp monoclonal.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
milk levels of omalizumab were 0.15% of the maternal serum concentration.
concentraţiile din lapte ale omalizumab au fost 0,15% din concentraţiile serice materne.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each pre-filled syringe of 1 ml solution contains 150 mg of omalizumab.
fiecare seringă pre- umplută de 1 ml conţine 150 mg de omalizumab.
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
anaphylactic reaction, other serious allergic conditions, anti- omalizumab antibody development
reacţie anafilactică, alte afecţiuni alergice grave, apariţia de anticorpi anti-omalizumab
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
omalizumab reduced the rate of asthma exacerbations by 19% (p = 0.153).
omalizumab a redus frecvenţa crizelor de astm bronşc cu 19% (p = 0,153).
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
after reconstitution one vial contains 125 mg/ml of omalizumab (75 mg in 0.6 ml).
după reconstituire, un flacon conţine omalizumab 125 mg/ml (75 mg în 0,6 ml).
Last Update: 2017-04-26
Usage Frequency: 2
Quality: